During his tenure at Hologic, Robert A. Cascella's stock holdings fluctuated considerably. At one point, his wealth in Hologic shares peaked above $39 million. Over the years, these holdings displayed a notable range, reflecting both the ups and downs associated...

During his tenure at Hologic, Robert A. Cascella's stock holdings fluctuated considerably. At one point, his wealth in Hologic shares peaked above $39 million. Over the years, these holdings displayed a notable range, reflecting both the ups and downs associated with the health tech market. For example, in early 2019, his holdings reached about $24 million, but by early 2024, they increased to approximately $39 million, showcasing substantial growth. This trajectory indicates how executive decisions and company performance can influence personal wealth, providing insight into Cascella's strategic role in the business.